medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2017, Number 2

<< Back Next >>

Cir Card Mex 2017; 2 (2)

La influencia de factores clínico patológicos del donador cardiaco en la frecuencia de la morbimortalidad de pacientes trasplantados de corazón a los 3 y 6 meses post-trasplante

Aguilar-Peña A, Zetina-Tun HJ, Acosta-Jiménez E, Cruz-López OD, Lezama-Urtecho CA, Careaga-Reyna G

Language: Spanish
References: 10
Page: 53-56
PDF size: 225.28 Kb.


ABSTRACT

Objective. To determine the influence of pathological clinical factors of the cardiac donor on the frequency of morbidity and mortality of transplanted heart patients at 3 and 6 months after transplantation.
Material and method. The study was conducted at our institution from January 1, 2014 to December 31, 2015. The whole sample included in this study was 35 recipients.
Results. Aortic biopsies resulted in pathology in 21 cases, of which, the most frequent was fibrosis and sclerosis. Pulmonary artery biopsies resulted in pathology in 17 cases, of which, the most frequent was fibrosis and sclerosis as well as in the aorta. Finally, biopsies collected from the left atrial appendage resulted in a greater variety of histological changes, again reporting fibrosis as the most frequent of the abnormalities, as well as hypertrophy and hypoxia, and only 5 cases free of pathology.
Conclusions. It was observed that the samples collected from the cardiac graft, although they resulted in abnormalities reported by pathology, did not correlate with the survival of the recipient at the time of transplantation, nor at 3 and 6 months after transplantation.


REFERENCES

  1. García-Pavía P, Gómez-Bueno M, Segovia J, Alonso-Pulpón LA. Trasplante cardiaco.Medicine 2009;42: 2838-2842.

  2. Jaramillo N, Segovia J, Gómez-Bueno M, et al. Características de los pacientescon supervivencia mayor de 20 años tras un trasplante cardiaco. Rev Esp Cardiol2013;66:797-802.

  3. Kobashigawa J, Zuckermann A, Macdonald P, et al. Report from a consensusconference on primary graft disfunction after cardiac transplantation, J Heart LungTransplant 2014;33: 327-340.

  4. Young JB, Hauptman PJ, Naftel DC, et al. Determinants of early graft failure followingcardiac transplantation, a 10-year, multi-institutional, multivariable analysis,J Heart Lung Transplant 2001; 20: 212 [una sola página].

  5. Hong KN, Iribarne A, Takayama H. Who is the high-risk recipient? Predictingmortality after herat trasplant using pretransplant donor and recipient rick factors.Ann Thorac Surg 2011; 92: 520-527.

  6. Kilic A, Weiss E, George T, Anaoutakis G, et al. What predicts long-term survivalafter heart transplantation? An analysis of 9,400 ten year survivors, Ann ThoracSurg. 2012;93:699-704.

  7. Careaga-Reyna G, Jiménez-Valdivia M, Argüero-Sánchez R. Trasplante de corazón.Preservación y técnica quirúrgica. Once años de experiencia Rev Invest Clin,2005;57:344-349.

  8. Careaga-Reyna G, Zetina-Tun H, Villaseñor-Colín C, Alvarez-Sánchez LM,Urías-Báez R, de la Cerda-Belmont GA. Procuración a distancia de corazón confines de trasplante. Cir Cir 2012;80:424-428.

  9. Careaga-Reyna G, Ramírez-Castañeda S, Ramírez-Castañeda A. Importancia dela evaluación terciaria del potencial donador en trasplante de corazón. Rev MexCardiol 2008;19:149-151.

  10. García del Moral-Garrido R, Bravo-Soto J, García del Moral-Martín R, et al. Biopsiadel implante renal: ¿tiene valor pronóstico?. Nefrología Sup Ext 2015;6:11-24.




2020     |     www.medigraphic.com